PERFECTION JUST GOT EVEN BETTER

Not an actual patient.

Sinclair has been committed to skin expertise since 1971,
and more recently the development of a safe, minimally invasive,
and effective portfolio of aesthetic treatments including Perfectha.

Learn more about Sinclair

Our best-in-class training platform: Sinclair College

Sinclair College

Upskill your knowledge on our website or app

Sinclair College offers Sinclair partner physicians; online educational courses, training programmes, and webinars. Discover all that Sinclair College has to offer by registering today.

290A5517 RT Min

Read up on Perfectha with our Physician brochure

The biocompatibility and performance of the entire Perfectha range have been clinically demonstrated. Perfectha complies with all safety standards required by health authorities and has been CE marked since 2007. Perfectha is registered and launched in more than 70 countries around the world. With more than 15 years of clinical use. 4.4 million syringes sold worldwide. Perfectha has established itself among the leaders in the aesthetic market.

View Perfectha Physician Brochure

Perfectha Particles

Contact Us

Reach out to our brilliant teams and get started with Perfectha. Please include your country and postcode.

Title

First Name

Last Name

Email

Speciality

Address 1

Address 2

Postcode

City

Country

Message

I Accept Website Terms & Conditions

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them.

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions. Perfectha is for intradermal and subcutaneous application and is implanted in the areas of the face and hands to fill skin depressions and also for the augmentation of tissue volume.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type, there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules, etc.), pain (which may be temporary or persistent in nature), transient hematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Perfectha distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit eifu.sinclairpharma.com for a copy of the Product Instructions for Use.